Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.
Bernstein AN, Talwar R, Handorf E, Syed K, Danella J, Ginzburg S, Belkoff L, Reese AC, Tomaszewski J, Trabulsi E, Singer EA, Jacobs B, Kutikov A, Uzzo R, Raman JD, Guzzo T, Smaldone MC, Correa A. Bernstein AN, et al. Among authors: belkoff l. JAMA Oncol. 2021 Oct 1;7(10):1467-1473. doi: 10.1001/jamaoncol.2021.2755. JAMA Oncol. 2021. PMID: 34292311 Free PMC article.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
Impact of COVID-19 on Initial Management and Evaluation of Prostate Cancer.
Bernstein AN, Talwar R, Handorf E, Syed K, Danella J, Ginzburg S, Belkoff L, Reese AC, Tomaszewski J, Trabulsi E, Jacobs B, Singer EA, Raman J, Smaldone M, Uzzo R, Guzzo T, Correa A. Bernstein AN, et al. Among authors: belkoff l. Urol Pract. 2021 Nov;8(6):668-675. doi: 10.1097/UPJ.0000000000000261. Epub 2021 Aug 23. Urol Pract. 2021. PMID: 37145514
Reply by Authors.
Bernstein AN, Talwar R, Handorf E, Syed K, Danella J, Ginzburg S, Belkoff L, Reese AC, Tomaszewski J, Trabulsi E, Jacobs B, Singer EA, Raman J, Smaldone M, Uzzo R, Guzzo T, Correa A. Bernstein AN, et al. Among authors: belkoff l. Urol Pract. 2021 Nov;8(6):675. doi: 10.1097/UPJ.0000000000000261.02. Epub 2021 Aug 23. Urol Pract. 2021. PMID: 37145535 No abstract available.
Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men.
Epstein M, Syed K, Danella J, Ginzburg S, Belkoff L, Tomaszewski J, Trabulsi E, Singer EA, Jacobs BL, Raman JD, Guzzo TJ, Uzzo R, Reese AC. Epstein M, et al. Among authors: belkoff l. Prostate Cancer Prostatic Dis. 2023 Oct 11. doi: 10.1038/s41391-023-00727-6. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37821578
18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE.
Solanki AA, Savir-Baruch B, Liauw SL, Michalski J, Tward JD, Vapiwala N, Teoh EJ; LOCATE study group. Solanki AA, et al. Pract Radiat Oncol. 2020 Sep-Oct;10(5):354-362. doi: 10.1016/j.prro.2020.05.007. Epub 2020 May 25. Pract Radiat Oncol. 2020. PMID: 32464368
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.
De La Cerda J, Dunshee C, Gervasi L, Sieber P, Belkoff L, Tutrone R, Lu S, Gatoulis SC, Brown B, Migoya E, Shore N. De La Cerda J, et al. Among authors: belkoff l. Target Oncol. 2023 May;18(3):383-390. doi: 10.1007/s11523-023-00967-5. Epub 2023 Apr 15. Target Oncol. 2023. PMID: 37060432 Free PMC article. Clinical Trial.
53 results